Toggle navigation
About Us 
Overview
Management Team
Board of Directors
Technology 
Focus on Eye Care
MPP Technology
Pipeline
Investors & Media 
Overview
Press Releases
Events & Presentations
Corporate Governance
Analyst Coverage
Stock Information
SEC Filings
Annual Reports & Proxies
Investor FAQs
Contact 
Contact Info
Business Development
Careers
About Us 
Overview
Management Team
Board of Directors
Technology 
Focus on Eye Care
MPP Technology
Pipeline
Investors & Media 
Overview
Press Releases
Events & Presentations
Corporate Governance
Analyst Coverage
Stock Information
SEC Filings
Annual Reports & Proxies
Investor FAQs
Contact 
Contact Info
Business Development
Careers
Previous
Next
Our Platform
Kala’s MPP nanoparticles are designed to penetrate mucus barriers
Learn More
Our Focus
Leveraging our MPP technology to enhance delivery to ocular tissues
Learn More
Our Pipeline
Kala is developing a diversified pipeline of ophthalmic product candidates 
Learn More
News
November 8, 2018
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
November 7, 2018
Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
October 25, 2018
Kala Pharmaceuticals Appoints Steven Zhang as Vice President of Medical Affairs
Read More
About Us
Overview
Management Team
Board of Directors
Technology
Focus on Eye Care
MPP Technology
Pipeline
Investors & Media
Overview
Press Releases
Events & Presentations
Corporate Governance
Analyst Coverage
Stock Information
SEC Filings
Annual Reports & Proxies
Investor FAQs
Contact
Contact Info
Business Development
Careers
© 2018 Kala Pharmaceuticals  |  
Terms of Use
  |  
Privacy Statement
© 2018 Kala Pharmaceuticals
Terms of Use
Privacy Statement